Short Interest in Nutex Health Inc. (NASDAQ:NUTX) Expands By 40.3%

Nutex Health Inc. (NASDAQ:NUTX - Get Free Report) was the recipient of a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 84,600 shares, a growth of 40.3% from the March 15th total of 60,300 shares. Approximately 2.6% of the company's shares are short sold. Based on an average daily trading volume, of 56,800 shares, the short-interest ratio is presently 1.5 days.

Insider Activity at Nutex Health

In related news, CFO Jon Christian Bates acquired 1,000 shares of the business's stock in a transaction on Tuesday, April 8th. The shares were bought at an average cost of $81.81 per share, with a total value of $81,810.00. Following the completion of the transaction, the chief financial officer now directly owns 4,888 shares of the company's stock, valued at $399,887.28. This trade represents a 25.72 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 38.52% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of the company. Bank of America Corp DE boosted its holdings in shares of Nutex Health by 6,590.3% in the 4th quarter. Bank of America Corp DE now owns 2,074 shares of the company's stock valued at $66,000 after buying an additional 2,043 shares during the period. Beaird Harris Wealth Management LLC bought a new position in Nutex Health during the 3rd quarter worth $69,000. Northern Trust Corp bought a new position in Nutex Health during the 4th quarter worth $200,000. Baader Bank Aktiengesellschaft acquired a new stake in Nutex Health in the fourth quarter worth $206,000. Finally, Millennium Management LLC bought a new stake in Nutex Health in the fourth quarter valued at $213,000. Institutional investors own 5.32% of the company's stock.

Nutex Health Stock Up 8.8 %

NASDAQ NUTX traded up $12.11 during mid-day trading on Friday, reaching $149.00. 154,600 shares of the company's stock traded hands, compared to its average volume of 55,069. The company has a fifty day simple moving average of $71.04 and a 200-day simple moving average of $46.10. Nutex Health has a 1-year low of $4.16 and a 1-year high of $151.30. The company has a market cap of $823.67 million, a price-to-earnings ratio of -15.87 and a beta of 0.27. The company has a current ratio of 1.77, a quick ratio of 1.74 and a debt-to-equity ratio of 3.36.

Nutex Health (NASDAQ:NUTX - Get Free Report) last issued its quarterly earnings results on Monday, March 31st. The company reported $11.12 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.09) by $11.21. The business had revenue of $81.30 million during the quarter, compared to analyst estimates of $81.13 million. Nutex Health had a negative net margin of 14.09% and a negative return on equity of 51.27%.

Wall Street Analyst Weigh In

Separately, Maxim Group lifted their price objective on shares of Nutex Health from $75.00 to $100.00 and gave the company a "buy" rating in a research note on Tuesday, April 8th.

Nutex Health Company Profile

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.